John E. Langenfeld
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Molecular Biology top 10%
- TGF-β signaling in diseases
- Retinoids in leukemia and cellular processes
- RNA modifications and cancer
Papers in
-
- Lung Cancer Diagnosis and Treatment 9
- Medical Imaging and Pathology Studies 3
- Lung Cancer Treatments and Mutations 3
-
- TGF-β signaling in diseases 12
- Retinoids in leukemia and cellular processes 4
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Elaine M. Langenfeld (9 shared papers)Ethan Dmitrovsky (7 shared papers)Valerie W. Rusch (6 shared papers)David S. Klimstra (3 shared papers)Fulvio Lonardo (4 shared papers)Peter W. T. Pisters (1 shared paper)Ennapadam S. Venkatraman (1 shared paper)David Sekula (2 shared papers)
- Journals
- Cell Communication and Signaling (3 papers)Molecular Cancer Research (2 papers)Journal of Surgical Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Clinical Lung Cancer (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
John E. Langenfeld
47 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 99
- Oncology 685
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 457
- Neurology 210
- Biochemistry 86
Countries citing papers authored by John E. Langenfeld
This map shows the geographic impact of John E. Langenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Langenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Langenfeld more than expected).
Fields of papers citing papers by John E. Langenfeld
This network shows the impact of papers produced by John E. Langenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Langenfeld. The network helps show where John E. Langenfeld may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Langenfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. | 1997 | 355 |
| 2 | 2004 | 244 | |
| 3 | 1997 | 180 | |
| 4 | 2019 | 176 | |
| 5 | 1997 | 170 | |
| 6 | 2019 | 161 | |
| 7 | 2005 | 118 | |
| 8 | Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. | 1999 | 113 |
| 9 | 1999 | 90 | |
| 10 | 2005 | 76 | |
| 11 | Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. | 1996 | 75 |
| 12 | Red cell deformability is an early indicator of infection. | 1991 | 67 |
| 13 | 2007 | 54 | |
| 14 | 2015 | 47 | |
| 15 | 2005 | 45 | |
| 16 | 2013 | 45 | |
| 17 | 2015 | 43 | |
| 18 | 2016 | 39 | |
| 19 | 2013 | 32 | |
| 20 | Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. | 1995 | 26 |
About John E. Langenfeld
John E. Langenfeld is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Rheumatology and Surgery, having authored 50 papers that have together received 2.4k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Retinoids in leukemia and cellular processes (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Heterotopic Ossification and Related Conditions (3 papers), Esophageal Cancer Research and Treatment (3 papers), Medical Imaging and Pathology Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (685 citations), Molecular Biology (1.1k citations), Pulmonary and Respiratory Medicine (457 citations), Neurology (210 citations) and Biochemistry (86 citations). John E. Langenfeld has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Elaine M. Langenfeld, Ethan Dmitrovsky, Valerie W. Rusch, David S. Klimstra, Fulvio Lonardo, Peter W. T. Pisters, Ennapadam S. Venkatraman, David Sekula, Hiroaki Kiyokawa and Jay Boyle. Their work appears in journals such as Cell Communication and Signaling, Molecular Cancer Research, Journal of Surgical Research, Proceedings of the National Academy of Sciences and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.